Allogeneic hematopoietic stem-cell transplantation (allo-HSCT) recipients are especially
vulnerable to coronavirus disease 19 (COVID-19), because of their profound …

Background Natural disasters and pandemics can be highly challenging to blood supply
chains. This review aimed to assess the impacts of pandemics and natural disasters on …

For more than 2 years, COVID-19 has been holding the world at awe with new waves of
infections, novel mutants, and still limited (albeit improved) means to combat SARS-CoV-2 …

Attrition of young adult registry members is a significant issue impacting hematopoietic stem
cell (HSC) donation registries, including the Be The Match registry in the US. The resulting …

Introduction To explore the impact of donors' COVID-19 status on allogeneic stem cell
transplantation (allo-HSCT), we compared the transplant outcomes of 74 participants …

717 LETTERS collected within 14 days subsequent to contact exposure may be recalled as
a precautionary measure.” 1 The European CDC is still recommending that “Donor …

Abstract COVID-19 convalescent plasma (CCP) could improve the clinical outcome of
COVID-19 patients when high-titer CCP is administered in early stages of disease. However …

From COVID pandemic spread until now, many HSCT unrelated donor registries
recommend as a precaution a systematic COVID‐19 testing for all donors during the …

Introduction: In case of newly emerging pathogens, convalescent plasma (CP) is often the
only early available treatment option. It has been shown that different IgG subclasses …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has deeply
impacted hematopoietic stem cell (HSC) donation and transplantation. Numerous changes …